Table 3

Differential mRNA expression in DLBCL with 9p21 deletions in an independent set of 36 patients assessed by qRT-PCR

Gene identityChromosomal locationFunctionExpressionlogFCP
ACY1 3p21.1 Hydrolysis of aminoacids High .72 .041 
BCL2 18q21 Apoptosis High 1.03 .047 
BLNK 10q23 B-cell adaptor High .73 .051 
ENTPD1 10q24 Diphosphohydrolase High .53 .196 
FOXP1 3p14.1 Transcription factor High .74 .099 
FUT8 14q24.3 Fucosylation High .99 .022 
IGF2BP3 7p11 RNA synthesis High 1.38 .022 
IMPDH2 3p21.2 Guanine nucleotide biosynthesis High .54 .167 
JAK2 9p24 Tyrosine kinase High .75 .048 
PIM1 6p21.2 Protein kinase High .57 .156 
RASGRF1 15q24.2 Ras pathway High 1.16 .114 
RFC4 3q27 DNA elongation High .73 .015 
RMI1 9q21.32 Processing of homologous recombination High .71 .021 
RPL15 3p24.2 Ribosomal protein High .58 .101 
SLBP 4p16.3 Histone hair-pin binding protein High .98 .001 
TMEM97 17q11.2 Transmembrane protein High .52 .061 
AUTS2 7q11 Tumor suppressor gene Low −1.49 .033 
CDKN2A 9p21 G1/S regulation Low −4.06 .000 
CDKN2B 9p21 G1/S regulation Low −1.25 .010 
DENND3 8q24.3 Unknown Low −1.31 .015 
ITPKB 1q42.13 Inositol phosphokinase Low −1.46 .003 
LMO2 11p13 Cystein-rich protein Low −2.19 .001 
LPP 3q28 Transcription factor Low −.52 .165 
PDXK 21q22.3 Pyridoxine kinase Low −.99 .001 
PLAU 10q24 Plasminogen activator Low −.90 .034 
PPAP2B 1pter-p22 Phosphatidic acid phosphatase Low −.55 .175 
UPP1 7p12.3 Uridine phosphorylase Low −1.14 .010 
Gene identityChromosomal locationFunctionExpressionlogFCP
ACY1 3p21.1 Hydrolysis of aminoacids High .72 .041 
BCL2 18q21 Apoptosis High 1.03 .047 
BLNK 10q23 B-cell adaptor High .73 .051 
ENTPD1 10q24 Diphosphohydrolase High .53 .196 
FOXP1 3p14.1 Transcription factor High .74 .099 
FUT8 14q24.3 Fucosylation High .99 .022 
IGF2BP3 7p11 RNA synthesis High 1.38 .022 
IMPDH2 3p21.2 Guanine nucleotide biosynthesis High .54 .167 
JAK2 9p24 Tyrosine kinase High .75 .048 
PIM1 6p21.2 Protein kinase High .57 .156 
RASGRF1 15q24.2 Ras pathway High 1.16 .114 
RFC4 3q27 DNA elongation High .73 .015 
RMI1 9q21.32 Processing of homologous recombination High .71 .021 
RPL15 3p24.2 Ribosomal protein High .58 .101 
SLBP 4p16.3 Histone hair-pin binding protein High .98 .001 
TMEM97 17q11.2 Transmembrane protein High .52 .061 
AUTS2 7q11 Tumor suppressor gene Low −1.49 .033 
CDKN2A 9p21 G1/S regulation Low −4.06 .000 
CDKN2B 9p21 G1/S regulation Low −1.25 .010 
DENND3 8q24.3 Unknown Low −1.31 .015 
ITPKB 1q42.13 Inositol phosphokinase Low −1.46 .003 
LMO2 11p13 Cystein-rich protein Low −2.19 .001 
LPP 3q28 Transcription factor Low −.52 .165 
PDXK 21q22.3 Pyridoxine kinase Low −.99 .001 
PLAU 10q24 Plasminogen activator Low −.90 .034 
PPAP2B 1pter-p22 Phosphatidic acid phosphatase Low −.55 .175 
UPP1 7p12.3 Uridine phosphorylase Low −1.14 .010 

Boldface indicates genes included in the activated B cell/germinal center B cell (ABC/GCB) signature.

DLBCL indicates diffuse large B-cell lymphoma; and FC, fold change.

Close Modal

or Create an Account

Close Modal
Close Modal